Luye Pharma Group Ltd.
General ticker "LYPHF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.3B (TTM average)
Luye Pharma Group Ltd. does not follow the US Stock Market performance with the rate: -44.8%.
Estimated limits based on current volatility of 0.0%: low 0.27$, high 0.27$
Short-term LYPHF quotes
Long-term LYPHF plot
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | CNY6,145.58MM |
| Operating Expenses | CNY4,927.14MM |
| Operating Income | CNY1,218.44MM |
| Non-Operating Income | CNY-298.18MM |
| Interest Expense | CNY668.88MM |
| R&D Expense | CNY403.24MM |
| Income(Loss) | CNY920.26MM |
| Taxes | CNY232.81MM |
| Net Income(Loss)* | CNY602.78MM |
| Stockholders Equity | CNY16,080.67MM |
| Inventory | CNY957.02MM |
| Assets | CNY32,841.92MM |
| Operating Cash Flow | CNY1,783.15MM |
| Capital expenditure | CNY1,002.72MM |
| Investing Cash Flow | CNY-3,986.35MM |
| Financing Cash Flow | CNY1,787.36MM |
| Earnings Per Share** | CNY0.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.